Assessment of Trimetazidine Treatment in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention

Table 2

Pharmacologic treatments.

	TMZ group (n = 200)	Control group (n = 201)	value
Aspirin	200	201	—
Ticagrelor	200	201	—
Anticoagulant (LMWH)	200	201	—
β-Blockers	92	98	0.580
ACEIs/ARBs	78	91	0.203
Statins	198	199	1.000
Nitrates	142	151	0.352

LMWH, low-molecular-weight heparin calium; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.